Suite 420A
Philadelphia, PA 19107
(215) 955-8874
Most Recent Peer-reviewed Publications
- Final outcomes of escalated melphalan 280 mg/m2with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival
- Sirolimus enhances remission induction in patients with high risk acute myeloid leukemia and mTORC1 target inhibition
- Higher rates of relapse in maternal recipients of haploidentical hematopoietic stem cell transplantation from adult offspring donors for AML and myelodysplastic syndrome
- Relapsed Multiple Myeloma Presenting as Intracranial Plasmacytoma and Malignant Pericardial Effusion following Recent Allogeneic Stem Cell Transplantation
- Structure of Nascent Chromatin Is Essential for Hematopoietic Lineage Specification
Medical School
Jefferson Medical College - 1976
Residency
Albert Einstein College of Medicine, NY
Fellowship
Memorial Sloan-Kettering Cancer Center, NY
Board Certification
Medical Oncology
Hematology
Internal Medicine
Hospital Appointment
Thomas Jefferson University Hospital
Methodist Hospital Division of Thomas Jefferson University Hospital
University Appointment
Chairman, Medical Oncology
Professor
Research & Clinical Interests
Medical Oncology, Hematology-Oncology, Bone Marrow Transplant, Hematologic Malignancies, Leukemia, Lymphoma
Dr. Flomenberg is the Chairman of Medical Oncology and also heads the Hematologic Malignancies, Blood and Marrow Transplantation (BMT) Program. He has had a longstanding interest in the immunogenetics and immunology of stem cell transplantation, with the goal of making transplantation safer and more widely available.